> For the complete documentation index, see [llms.txt](https://docs.owkin.com/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://docs.owkin.com/explore-and-analyse-data/data-catalog/datasets-available-in-k-pro-free/mosaic-window.md).
# Mosaic Window
MOSAIC Window is a curated subset of the groundbreaking MOSAIC dataset, available through K Pro. It includes spatial omics and multimodal data from **60 patients** across five cancer types:
* **BLCA (Bladder Cancer):** 15 patients
* **OV (Ovarian Cancer):** 15 patients
* **GBM (Glioblastoma):** 10 patients
* **DLBCL (Diffuse Large B-cell Lymphoma):** 10 patients
* **MESO (Mesothelioma):** 10 patients
This unique resource enables researchers to explore tumor biology at near single-cell resolution, providing detailed insight into tumor and immune cell interactions.
#### **MOSAIC Window Patient Details**
**BLCA (15 patients):**
* Stage II and III urothelial carcinoma (one squamous cell carcinoma)
* Derived from upfront cystectomies
* Most patients receiving complete lymph node dissection
* Some treated with adjuvant chemotherapy, chemotherapy, or immune checkpoint inhibitors (ICI) at relapse, with or without radiotherapy
**OV (15 patients):**
* FIGO stage II to IV high grade serous carcinoma
* 7 baseline, 2 post-NACT, 6 relapse lesions
* Treated by upfront or post-NACT interval debulking surgeries and chemotherapy
* Additional treatments: Bevacizumab, PARP inhibitors, and ICI in first or later lines
**GBM (10 patients):**
* Glioblastoma as per WHO 2021 definition, all IDH wildtype
* 6 unmethylated and 4 methylated MGMT promoter samples
* Obtained from baseline surgery before standard adjuvant therapy
* 1 to 3 brain tumor sites, tumor sizes 27 to 80mm diameter
* 5 patients received Bevacizumab at relapse
**DLBCL (10 patients):**
* Ann Arbor stage III or IV
* 3 Activated B-cell-like type (ABC), 6 Germinal center B-cell group (GCB), 1 unknown subtype
* Obtained at baseline before R-CHOP therapy
* Targeted interventions at relapse
**MESO (10 patients):**
* Stage I to III pleural mesotheliomas
* 5 epithelioid, 5 biphasic
* 9 baseline biopsies/surgeries, 1 post-NACT sample
* 4 patients treated by NACT (1 partial response, 3 progressive diseases)
* 4 patients received anti-PD-1 ICI at relapse (monotherapy or combination with anti-CTLA4)
---
# Agent Instructions
This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com.
## Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.
Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter:
```
GET https://docs.owkin.com/explore-and-analyse-data/data-catalog/datasets-available-in-k-pro-free/mosaic-window.md?ask=&goal=
```
`ask` is the immediate question: it should be specific, self-contained, and written in natural language.
`goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.
Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.